Management of Chlamydia trachomatis genital tract infection in Genitourinary Medicine clinics in the United Kingdom's North Thames region 1999

International Journal of STD and AIDS

Volumn 12, Issue 3, 2001, Pages 204-208

  Dale, A W S ^a,b   Horner, P J ^c   Forster, G E ^b,d   Daniels, D ^b,e   Tomlinson, D ^b,f   Brook, M G ^b,g  

^a ST PANCRAS HOSPITAL   (United Kingdom)

^b North Thames Regional GU/HIV Audit Group   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Audit; Chlamydia trachomatis; GUM; Survey

Indexed keywords

NUCLEIC ACID;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL PRACTICE; DIAGNOSTIC TEST; FEMALE; HUMAN; MALE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COSTS AND COST ANALYSIS; DNA, BACTERIAL; ENGLAND; FEMALE; FEMALE UROGENITAL DISEASES; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MALE UROGENITAL DISEASES; MEDICAL AUDIT; MIDDLE AGED; OBSTETRICS AND GYNECOLOGY DEPARTMENT, HOSPITAL; POLYMERASE CHAIN REACTION; QUESTIONNAIRES; UROLOGY DEPARTMENT, HOSPITAL;

EID: 0035098953     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011916910     Document Type: Article

References (18)

1. National guideline for the management of Chlamydia trachomatis genital tract infection
2. Comparison of performance and cost-effectiveness of direct fluorescent antibody ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection
3. Lowering the cut off value of an automated chlamydia enzyme immunohssay and confirmation by PCR and direct immunofluorescent antibody test
4. Chlamydia trachomatis: Impact on human reproduction
5. Tests for infection with Chlamydia trachomatis
6. Universal prophylactics for Chlamydia trachomatis and aerobic vaginosis in women attending for suction termination of pregnancy: An audit of short-term health gains
7. Mailed, home-obtained urine specimens: A reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections
8. Postal urine specimens: Are they a feasible method for genital chlamydial infection screening?
9. Chlamydia in pregnancy: A randomised control trial of azithromycin and erythromycin
10. Single dose azithromycin for chiamydia in pregnant women
11. DNA methods should be used to detect Chlamydia trachomatis
12. Widening screening to detect Chlamydia trachomatis is more important than using DNA methods
13. Pooling of urine specimens for PCR testing: A cost saving strategy for Chlamydia trachomatis control programmes
14. The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infections
15. Knowledge of Chlamydia trachomatis infection in genitourinary medicine clinic attenders
16. The case for screening is made, but much detail remains to be worked out
17. New methods are needed to assess the burden of illness from chlamydia